Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Somford, D. M."" wg kryterium: Autor


Tytuł :
De FUTURE trial; een multicenter RCT naar MRI-geleide prostaatbiopten: Vergelijking van drie technieken van target biopten en vergelijking met systematische biopten
Autorzy :
Wegelin, O.
Exterkate, L.
Barentsz, J. O.
van der Leest, M. G.
Kelder, J. C.
Kummer, J. A.
Vreuls, W.
de Bruin, P. C.
de Vocht, T. F.
Nuininga, J. E.
Bosch, J. L. H. R.
Somford, D. M.
van Melick, H. H. E.
Pokaż więcej
Alternatywny tytuł :
The FUTURE trial: a multicenter RCT on MRI-guided prostate biopsies: Comparison of three techniques of targeted biopsies and comparison with systematic biopsies
Źródło :
Tijdschrift voor Urologie. 9(8):146-156
Czasopismo naukowe
Tytuł :
What is the effect of MRI with targeted biopsies on the rate of patients discontinuing active surveillance? A reflection of the use of MRI in the PRIAS study.
Autorzy :
Luiting HB; Department of Urology, Erasmus University Medical Centre Cancer Institute, Rotterdam, The Netherlands. .
Remmers S; Department of Urology, Erasmus University Medical Centre Cancer Institute, Rotterdam, The Netherlands.
Valdagni R; Department of Oncology and Haemato-oncology, Università degli Studi di Milano. Radiation Oncology 1, Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Boevé ER; Department of Urology, Sint Franciscus Hospital, Rotterdam, The Netherlands.
Staerman F; Department of Urology, Polycliniques REIMS-BEZANNES, Reims, France.
Rueb J; Department of Urology, Marien Hospital Herne, Herne, Germany.
Somford DM; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Pickles T; Department of Radiation Oncology, Vancouver Center, BC Cancer, Vancouver, BC, Canada.
Rannikko A; Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland.
Roobol MJ; Department of Urology, Erasmus University Medical Centre Cancer Institute, Rotterdam, The Netherlands.
Pokaż więcej
Corporate Authors :
PRIAS consortium
Źródło :
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2021 Apr 08. Date of Electronic Publication: 2021 Apr 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population.
Autorzy :
Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands. .; Institute for Medical Technology Assessment, Erasmus School of Health Policy and Management, Rotterdam, the Netherlands. .
Kuppen MCP; Institute for Medical Technology Assessment, Erasmus School of Health Policy and Management, Rotterdam, the Netherlands.
van den Eertwegh AJM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.
de Wit R; Department of Medical Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, the Netherlands.
Bergman AM; Division of Internal Medicine (MOD) and Oncogenomics, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
van Moorselaar RJA; Department of Urology, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.
Coenen JLLM; Department of Internal Medicine, Isala Klinieken, Zwolle, the Netherlands.
van den Bergh ACM; Department of Radiation Oncology, University Medical Center Groningen, Groningen, the Netherlands.
Somford DM; Department of Urology, Canisius Wilhemina Hospital, Nijmegen, the Netherlands.
Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands.
Aben KKH; Department for Health Evidence, Radboud University Medical Center, The Netherlands and Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
Uyl-de Groot CA; Institute for Medical Technology Assessment, Erasmus School of Health Policy and Management, Rotterdam, the Netherlands.
Pokaż więcej
Źródło :
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2021 Mar 21. Date of Electronic Publication: 2021 Mar 21.
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies